Chemistfrog
Chemistfrog
Send Message
Chemistfrog
Stop FollowingChemistfrog
View as an RSS Feed
View Chemistfrog's Articles BY TICKER:
- OncoSec's And Ziopharm's IL-12 Targeted Delivery Systems: Which Will Succeed?
-
Multiple Pending Catalysts Should Keep Investor Interest Strong For Rockwell Medical
- Potential DelMar Investors Await First 10Q Filings From The Sidelines
- 2 Medical Device Companies With Revolutionary Platforms
- Enzo Biochem's Intellectual Property Protection To Attract Investor Attention In 2013
- Detecting Investment Potential In Medical Diagnostics Companies
- Imminent Catalysts For Small Pharmaceuticals
- A Tale Of Three Pharmaceuticals: Getting Exciting In 2013
- DelMar IPO Obscurity Could Offer Investors Favorable Entry
- InVivo Therapeutics' Unique Technology Garnering Investor Interest
- Investor Watch List: Week of April 15 2013
- Biodel: Reemerging From Obscurity In 2013
- Small Pharma Watch List: Week Of April 8, 2013
- Telik: A Possible Investment, But Only After Much Consideration
- The Week Ahead Could Be Pivotal For These Small-Cap Companies' Stocks
- Apricus Biosciences: A Transformative Year Ahead
- Trovagene's Novel Diagnostics Platform To Garner Attention In 2013
- Pivotal Phase III Trial Data Ahead For 3 Development-Stage Small Pharma Companies
- Small Pharmas With Imminent Catalysts For March 2013
- Athersys' MultiStem Platform Tempts Big Pharma And Investors
-
Speculation On The Cause Of The OMONTYS Recall
- 3 Small Cap Radiopharmaceuticals With An Exciting 2013 Ahead
- Small Pharma Watch List: Week Of February 11th, 2013
- Pending Q4 Results: Dyax Partnerships Could Yield Sustained Growth For Investors
- Imminent Catalysts Should Keep Investor Interest Alive For Dara BioSciences
-
Imminent Catalysts Should Keep Investor Interest Alive For These Pharmaceuticals - Part II
- Imminent Catalysts Should Keep Investor Interest Alive For These 3 Pharmaceuticals
- Small-Pharma Watch List: Week Of January 28th
-
Soligenix: The Reintroduction
- Small Pharma Watch List: Week Of January 21st
- 'Top Of The Class' Small Pharma Investments For 2013 Part II
- Supernus Pharmaceuticals Readying For A Super Year Ahead
